Demographic, clinical, and ocular features in patients with late-onset behçet disease

Ocular Immunology and Inflammation

Volumn 20, Issue 2, 2012, Pages 119-124

  Hazirolan, Dicle ^a   Sungur, Gulten ^a   Duman, Sunay ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Anterior uveitis; Beh et disease; Late onset; Ocular involvement; Panuveitis

Indexed keywords

AZATHIOPRINE; COLCHICINE; CYCLOSPORIN;

ADULT; ARTICLE; BEHCET DISEASE; CATARACT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; EYE DISEASE; FEMALE; GENITAL ULCER; HUMAN; MALE; RETINA MACULA EDEMA; SECONDARY GLAUCOMA; SEX DIFFERENCE; SYMPTOM; UVEITIS; VISUAL ACUITY;

ADOLESCENT; ADULT; AGE OF ONSET; BEHCET SYNDROME; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; UVEITIS; VISUAL ACUITY; YOUNG ADULT;

EID: 84858199738     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2012.655882     Document Type: Article

References (38)

1. Mochizuki M, Akduman L, Nussenblatt RB. Behçet's disease. in Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St Louis: Mosby; 1996: 663-675.
2. International Study Group for Behçet's Disease. Evaluation of diagnostic ('classifcation') criteria in Behçet's disease: toward internationally agreed criteria. Lancet. 1990;335:1078-1080.
3. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med. 1999;341:1284-1291.
4. Poon W, Verity DH, Larkin GL, et al. Behçet's disease in patients of West African and Afro-Caribbean origin. Br J Ophthalmol. 2003;87:876-878. (Pubitemid 36765254)
5. Yazici H, Tuzun Y, Pazarli H. Infuence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis. 1984;43: 783-789. (Pubitemid 15190181)
6. Citirik M, Berker N, Songur MS, et al. Ocular manifestations of late-onset Behçet disease. Ophthalmologica. 2011;225:21-26.
7. Krause I, Uziel Y, Guedj D. Childhood Behçet's disease: clinical features and comparison with adult-onset disease. Rheumatology (Oxford). 1999;38:457-462. (Pubitemid 29507132)
8. Zafrakis P, Foster CS. Adamantiades-Behçet disease. In Foster CS, Vitale AT, eds. Diagnosis and Treatment of Uveitis. Philadelphia: Saunders; 2002: 632-652.
9. Altenburg A, Papoustis N, Orawa H, et al. Epidemiology and clinical manifestations of Adamantiades-Behçet disease in Germany: current pathogenetic concepts and therapeutic possibilities. J Dtsch Dermatol Ges. 2006;4:49-65.
10. Ando K, Fujino Y, Hijikata K, et al. Epidemiological features and visual prognosis of Behçet's disease. Jpn J Ophthalmol. 1999;43:312-317. (Pubitemid 29329392)
11. Zouboulis CC, Kötter I, Djawari D, et al. Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J. 1997;38:411-422. (Pubitemid 128516402)
12. Matsuo T, Itami M, Nakagawa H. The incidence and pathology of conjunctival ulceration in Behçet's syndrome. Br J Ophthalmol. 2002;86:140-143. (Pubitemid 34127534)
13. Nussenblatt RB, Whitcup SM, Palestine AG. Behçet's disease. In Nussenblatt RB, Whitcup SM, Palestine AG, eds. Uveitis: Fundamentals and Clinical Practice. St Louis: Mosby; 1996: 334-353.
14. Colvard DM, Robertson DM, O'Duffy JD. The ocular manifestations of Behçet's disease. Arch Ophthalmol. 1977;95:1813-1817.
15. Zamir E, Bodaghi B, Tugal-Tutkun I. Conjunctival ulcers in Behçet's disease. Ophthalmology. 2003;110:1137-1141.
16. Atmaca LS. Fundus changes associated with Behçet's disease. Graefes Arch Clin Exp Ophthalmol. 1989;227:340-344. (Pubitemid 19180482)
17. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol. 2004;138:373-380. (Pubitemid 39208563)
18. Sungur GK, Hazirolan D, Yalvac I, et al. Clinical and demographic evaluation of Behçet disease among different paedi-atric age groups. Br J Ophthalmol. 2009;93:83-87.
19. Fujikawa S, Suemitsu T. Behçet's disease in children: a nationwide retrospective survey in Japan. Acta Paediatr Jpn. 1997;39:285-289.
20. Tsai J, Chen GS, Lu LW et al. Late-onset Behçet's disease does not correlate with indolent clinical course: report of seven Taiwanese patients. J Eur Acad Dermatol Venereol. 2008;22:596-600. (Pubitemid 351541056)
21. Saricaoglu H, Karadogan SK, Bayazit N. Clinical features of late-onset Behçet's disease: report of nine cases. Int J of Dermatol. 2006;45:1284-1287. (Pubitemid 44688019)
22. Sungur G, Hazirolan D, Hekimoglu E, et al. Late-onset Behçet's disease: demographic, clinical, and ocular features. Graefes Arch Clin Exp Ophthalmol. 2010;248:1325-1330.
23. Main DM, Chamberlain MA. Clinical differentiation of oral ulceration in Behçet's disease. Br J Rheumatol. 1992;31:767.
24. Deuter CM, Kötter I, Wallace GR, et al. Behçet's disease: ocular effects and treatment. Prog Retin Eye Res. 2008;27:111-136.
25. Yazici H, Fresko I, Yurdakul S. Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol. 2007;3:148-155. (Pubitemid 46416263)
26. Magro CM, Crowson AN. Cutaneous manifestations of Behçet's disease. Int J Dermatol. 1995;34:159.
27. Yazici H, Chamberlain MA, Tuzun Y, et al. A comparative study of the pathergy reaction among Turkish and British patients with Behçet's disease. Ann Rheum Dis. 1984;43:74-75. (Pubitemid 14152981)
28. O'Duffy JD. Vasculitis in Behçet's disease. Rheumatol Dis Clin North Am. 1990;16:423-431.
29. Kidd D, Steuer A, Denman AM, et al. Neurological complications in Behçet's syndrome. Brain. 1999;122:2183-2194.
30. Ebert EC. Gastrointestinal manifestations of Behçet's disease. Dig Dis Sci. 2009;54:201-207.
31. Padula A, Ciancio G, Cantini F, et al. Coexisting Behçet's disease and spondyloarthritis. Clin Rheumatol. 1999; 18:499-500.
32. Evereklioglu C. Current concepts in the etiology and the treatment of Behçet disease. Surv Ophthalmol. 2005;50:297.
33. Demiroglu H, Barista I, Dundar S. Risk factor assessment and prognosis of eye involvement in Behçet's disease in Turkey. Ophthalmology. 1997;104:701-705. (Pubitemid 27171995)
34. Ozdal PC, Ortac S, Taskintuna I. Posterior segment involvement in ocular Behçet's disease. Eur J Ophthalmol. 2002;12:424-431. (Pubitemid 35428797)
35. Taylor SR, Singh J, Menezo V, et al. Behçet disease: visual prognosis and factors infuencing the development of visual loss. Am J Ophthalmol. 2011;152:1059-1066.
36. Davatchi F, Shahram F, Shams H, et al. Gender infuence on ocular manifestations and their outcome in Behcet's Disease: a long-term follow-up of up to 20 years. Clin Rheumatol. 2011;30:541-547.
37. Sáenz-Francés F, Elías-de-Tejada M, Martínez-de-la-Casa JM, et al. Ocular infammatory signs observed in a cohort of Spanish patients with Behçet disease and ocular infamma-tion. Eur J Ophthalmol. 2008 Jul-Aug;18(4):563-566.
38. Koh HJ. Ophthalmologic manifestation of Behcet's disease. In Bang D, Lee E, Lee S, eds. Behcet's Disease. Seoul: Design Mecca; 2000: 90-93.